Reduction in Depressive Symptoms in Patients with Breast Cancer Following Cognitive Behavioral Psychotherapy Intervention

Bela Sukma Ayunda; Sofiya Sofiya; M Iqbal Sunli; Arini Retno Palupi

doi:10.15408/avicenna.v5i1.37928

Reduction in Depressive Symptoms in Patients with Breast Cancer Following Cognitive Behavioral Psychotherapy Intervention

Bela Sukma Ayunda, Sofiya Sofiya, M Iqbal Sunli, Arini Retno Palupi

Abstract

Background: Breast cancer, a malignancy in breast tissue has the highest prevalence among women globally. Around 50% breast cancer patients have experienced depression caused by the illness and its treatments, which is alarming due to its effects on the treatment effectiveness and recovery. This study is performed to know the effects of cognitive behavioral therapy in decreasing depressive symptoms in breast cancer patients.

Methods: The researchers followed a structured and systematic approach sourced from seven databases: ScienceDirect, ResearchGate, PubMed, Google Scholar, Biomed Central, Taylor & Francis Online, and Pharmacophore. The keywords used in this study were “Breast cancer” AND “Cognitive Behavioral Therapy” AND “Depression”. The initial search yielded 1.190 journals. After applying the inclusion and exclusion criteria, 11 journals were found that met criteria. The search was limited to randomized controlled trials, assessed using the JBI critical appraisal for risk of bias.

Results: The result shows positive outcomes in breast cancer patients with depression comorbidity following the implementation of cognitive behavioral therapy intervention. These positive changes include enhanced problem-solving skills in relation to psychosocial and emotional aspects, improved adaptability to various situations, and decreasing depressive symptoms.

Conclusion: Cognitive behavioral therapy is effective in decreasing depressive symptoms in breast cancer patients

Keywords

Cognitive Behavioral Therapy, Depression, Breast cancer

References

Park S, Sato Y, Takita Y, et al. Mindfulness-Based Cognitive Therapy for Psychological Distress, Fear of Cancer Recurrence, Fatigue, Spiritual Well-Being, and Quality of Life in Patients With Breast Cancer—A Randomized Controlled Trial. J Pain Symptom Manage [homepage on the Internet] 2020;60(2):381–389. Available from: https://doi.org/10.1016/j.jpainsymman.2020.02.017

Teo I, Vilardaga JP, Tan YP, et al. A feasible and acceptable multicultural psychosocial intervention targeting symptom management in the context of advanced breast cancer. Psychooncology 2020;29(2):389–397.

Kementerian Kesehatan RI. Panduan Nasional Penanganan Kanker Payudara. 2015;Available from: http://kanker.kemkes.go.id/guidelines/PNPKPayudara.pdf

Zahedian E, Bahreini M, Ghasemi N, Mirzaei K. Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial. BMC Womens Health [homepage on the Internet] 2021;21(1):1–9. Available from: https://doi.org/10.1186/s12905-021-01258-9

Charalampopoulou M, Bacopoulou F, Syrigos KN, Filopoulos E, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial. Breast [homepage on the Internet] 2020;49:210–218. Available from: https://doi.org/10.1016/j.breast.2019.12.012

Bellver-Pérez A, Peris-Juan C, Santaballa-Beltrán A. Effectiveness of therapy group in women with localized breast cancer. Int J Clin Heal Psychol [homepage on the Internet] 2019;19(2):107–114. Available from: https://doi.org/10.1016/j.ijchp.2019.02.001

McQuaid JR, Lin EH, Barber JP, et al. Treatment of Depression Across Three Age Cohorts. Am Psychol Assoc 2019;1(February):1–36.

Holtdirk F, Mehnert A, Weiss M, Meyer B, Watzl C. Protocol for the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors. Trials 2020;21(1):1–11.

Ren W, Qiu H, Yang Y, et al. Randomized controlled trial of cognitive behavioural therapy for depressive and anxiety symptoms in Chinese women with breast cancer. Psychiatry Res 2019;271(March 2018):52–59.

Hjemdal O, Solem S, Hagen R, Kennair LEO, Nordahl HM, Wells A. A randomized controlled trial of metacognitive therapy for depression: Analysis of 1-year follow-up. Front Psychol 2019;10(AUG):1–9.

Stern AF. The Hospital Anxiety and Depression Scale. Occup Med (Chic Ill) 2014;64(5):393–394.

PPDGJ III. Pedoman Penggolongan dan Diagnosis Gangguan Jiwa di Indonesia III (PPDGJ-III). Jakarta Dep Kesehat Republik Indones 1993;1–408.

Hosseini SH, Rafiei A, Janbabai G, et al. Comparison of religious cognitive behavioral therapy, cognitive behavioral therapy, and citalopram on depression and anxiety among women with breast cancer: A study protocol for a randomized controlled trial. Asian J Pharm Res Heal Care 2018;8(3):55–62.

Bach B, First MB. Application of the ICD-11 classification of personality disorders. BMC Psychiatry 2018;18(1):1–14.

Cully J, Dawson D, Hamer J, Tharp A. A Therapist’s Guide to Brief Cognitive Behavioral Therapy - therapists_guide_to_brief_cbtmanual.pdf. 2020;1–164. Available from: http://www.mirecc.va.gov/visn16/docs/therapists_guide_to_brief_cbtmanual.pdf

Lai HL, Chen CI, Lu CY, Huang CY. Cognitive behavioral therapy plus coping management for depression and anxiety on improving sleep quality and health for patients with breast cancer. Brain Sci 2021;11(12).

Zhang L, Liu X, Tong F, et al. Cognitive behavioral therapy for anxiety and depression in cancer survivors: a meta-analysis. Sci Rep [homepage on the Internet] 2022;12(1):1–12. Available from: https://doi.org/10.1038/s41598-022-25068-7

DOI: https://doi.org/10.15408/avicenna.v5i1.37928 Abstract - 0